@article{ref1,
title="Experience with paraquat poisoning in a respiratory intensive care unit in North India",
journal="Singapore medical journal",
year="2006",
author="Agarwal, R. and Srinivas, R. and Aggarwal, A. N. and Gupta, D.",
volume="47",
number="12",
pages="1033-1037",
abstract="INTRODUCTION: Paraquat poisoning is an uncommon entity in India. We report our experience of managing five patients with paraquat poisoning using immunosuppressive therapy. METHODS: Retrospective analysis of 84 patients admitted with a diagnosis of poisoning over the last eight years was performed. The data were presented in a descriptive fashion. RESULTS: Five (5.9 percent) out of the 84 patients were admitted with a diagnosis of paraquat poisoning. All patients were mechanically ventilated. All patients had hepatic failure with median peak bilirubin being 22.1 +/- 15.1 mg/dL (range 8.4-45.5). Four of the five patients had renal failure (median peak creatinine 3.8 +/- 1.5 mg/dL; range 3.4-11.1) requiring renal replacement therapy. All patients were treated with intravenous methylprednisolone 15 mg/kg/day for three consecutive days and intravenous cyclophosphamide 10 mg/kg/ day for two consecutive days, followed by intravenous dexamethasone 4 mg thrice a day until recovery or death. Two out of the five patients survived. Three died because of severe acute respiratory distress syndrome and multiorgan dysfunction syndrome. CONCLUSION: Paraquat poisoning is an uncommon entity in India, and is associated with a high mortality rate. There is a potential role for immunosuppressive therapy in patients with moderate to severe poisoning.<p /><p>Language: en</p>",
language="en",
issn="0037-5675",
doi="",
url="http://dx.doi.org/"
}